Uusi divisioona toimittaa edistyneitä puhdastiloja ja suojatiloja biotieteiden sektorille

The launch marks a strategic expansion of Vanguard’s capabilities into adjacent markets where demand is growing for high quality, compliant and rapidly deployable technical environments. Vanguard Life Sciences will support organisations operating across pharmaceutical manufacturing, biotechnology, research laboratories, genomics and advanced therapies, including cell and gene therapy.

Building on Vanguard’s long-established expertise in delivering complex technical environments through mobile and modular facilities, Vanguard Life Sciences will provide a faster and more flexible alternative to traditional construction. Its facilities are designed as complete buildings, using modern methods of construction to help organisations expand research capability, scale manufacturing and bring new infrastructure online more efficiently.

Extending trusted Vanguard expertise into life sciences

For more than two decades, Vanguard has delivered highly technical healthcare environments in regulated settings. Vanguard Life Sciences builds on that heritage by applying the same focus on precision, quality and reliability to the life sciences sector.

The new division will deliver cleanroom and containment environments that support a wide range of operational requirements, from early-stage innovation and pilot manufacturing through to long-term pharmaceutical production. Across its portfolio, Vanguard Life Sciences offers three complementary solution families:

Contained solutions for rapid deployment and specialist requirements. These are well suited to temporary production capacity, pilot batches, quality control overflow and other urgent or flexible needs.

Mobile and demountable facilities for short- to medium-term programmes where speed, flexibility and location agility matter. These can support research and development, diagnostic services, clinical trials and decant space during refurbishment projects.

Modular MMC facilities for permanent, fully integrated cleanroom environments designed for long-term use. These can support sterile and non-sterile manufacturing, fill-finish, laboratories and other high performance technical applications.

Supporting organisations at different stages of growth

Vanguard Life Sciences has been developed to meet the needs of organisations at different stages of maturity.

For early-stage biotech and innovation-led businesses, the offer focuses on speed to set-up, financial flexibility and space that can evolve as requirements develop. The proposition is designed to help organisations reach key milestones faster, protect cashflow and avoid unnecessary infrastructure complexity.

For established pharmaceutical organisations, the emphasis is on engineered reliability, predictable programmes, seamless integration with existing utilities and processes, and long-term lifecycle performance. Vanguard Life Sciences is positioned to support complex sites where operational continuity, compliance and minimising disruption are critical.

Collaboration with Enbloc

The launch of Vanguard Life Sciences is supported through a collaboration with Enbloc, a specialist contractor delivering high quality cleanrooms, containment suites and laboratory environments. Together, Vanguard Life Sciences and Enbloc bring complementary expertise in modular infrastructure delivery, technical engineering and controlled environments.

This collaboration strengthens Vanguard’s ability to support life sciences organisations with facilities that meet demanding operational and regulatory requirements, while benefiting from the speed, precision and predictability of modern construction methods.

Find out more

Vanguard Life Sciences will support organisations across the UK and the Republic of Ireland and will draw on the wider expertise, resources and experience across the Vanguard business.

To learn more, visit the Vanguard Life Sciences website or contact the team to discuss your requirements.